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Background: Epidemiological studies suggest that hyponutrition during the fetal period increases the risk of
mental disorders such as attention deficit hyperactivity disorder and autism-spectrum disorder, which has been
experimentally supported using animal models. However, previous experimental hyponutrition or protein-restricted
(PR) diets affected stages other than the fetal stage, such as formation of the egg before insemination, milk
composition during lactation, and maternal nursing behavior.
Results: We conducted in vitro fertilization and embryo transfer in mice and allowed PR diet and folic acid-supplemented
PR diet to affect only fetal environments. Comprehensive phenotyping of PR and control-diet progenies showed
moderate differences in fear/anxiety-like, novelty-seeking, and prosocial behaviors, irrespective of folic-acid
supplementation. Changes were also detected in gene expression and genomic methylation in the brain.
Conclusions: These results suggest that epigenetic factors in the embryo/fetus influence behavioral and
epigenetic phenotypes of progenies. Significant epigenetic alterations in the brains of the progenies induced by
the maternal-protein restriction were observed in the present study. To our knowledge, this is first study to
evaluate the effect of maternal hyponutrition on behavioral phenotypes using reproductive technology.
Keywords: Maternal nutrition, In vitro fertilization, Behavioral phenotypes, Gene expression and DNA
methylationBackground
Genetic factors are known to influence susceptibility to
psychiatric disorders, including schizophrenia, bipolar
disorder, major depressive disorder, autism-spectrum
disorder (ASD), and attention deficit hyperactivity
disorder (AD/HD) [1]. However, recent studies have
revealed that environmental and nutritional factors also
affect neuronal functions, probably via epigenetic mech-
anisms [2–5]. In the field of metabolic diseases, “Devel-
opmental Origins of Health and Disease” (DOHaD) is
the concept that in utero experiences reprogram suscep-
tibility to adult metabolic diseases [6]. It is of interest to
test if this concept is applicable to behavioral symptoms* Correspondence: tfuruse@brc.riken.jp
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Several studies using rodent models have been con-
ducted to evaluate the effects of maternal hyponutrition
on phenotypes of progenies. Restricted feeding in
mothers of mice or rats caused body weight restriction,
developmental anomalies, changes in metabolic pheno-
types, patterns of gene expression, and DNA methyla-
tion in progenies [7]. Isocaloric diets, such as the protein
restriction (PR) model, are fed in an alternative restric-
tion of the diet [8, 9] by compensating shortage of
energy source with carbohydrates [8]. Hence, protein-
carbohydrate balance is altered in the PR, making it suit-
able for evaluating the effects of maternal nutritional
imbalance, and not that of calorie shortage [10]. Several
reports have examined the interactions between
maternal-protein restriction and adult phenotypic/epi-
genetic alterations [8, 11–13].le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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Furuse et al. Genes & Nutrition  (2017) 12:1 Page 2 of 12Maternal PR diet, however, affects not only fetal environ-
ments but also formation of the egg before insemination,
nutritional condition of maternal milk, and maternal nurs-
ing behavior, and therefore, it has potential confounding
variables at different stages. In the present study, we per-
formed in vitro fertilization (IVF) to produce neonates and
then obtained progenies that were adopted by foster
mothers before weaning. This allowed the PR diet to affect
only the fetal stage of development.
Methods
Ethics statement of animal experiments
All procedures described here were reviewed and ap-
proved by the Institutional Animal Care and Use Com-
mittee of RIKEN Tsukuba Branch and were performed
in accordance with the RIKEN Guiding Principles for
the Care and Use of Laboratory Animals (No. 10-013).
Experimental design
The experimental design is described briefly in Fig. 1.
IVF and embryo transfer (ET) techniques were used for
mouse production. Female ICR mice, an outbred stock
from the Swiss mouse developed in the Institute of
Cancer Research [14], were used as recipient and foster
mothers. Embryos were generated by fertilizing the eggs
and sperm of C57BL/6J (B6) mice that had consumed a
normal diet (CE-2, CLEA Japan, Inc., Tokyo, Japan). CE-
2 is a rodent diet used for rearing and breeding. The diet
consists of crude sources of protein (soybean waste, white-
fish meal, and yeast), fat (cereal germ and soybean oil),
and carbohydrate (wheat flour and corn). Detailed ingredi-
ents of the CE-2 diet are described on the webpage of the
supplier (http://www.clea-japan.com/en/diets/diet_a/a_03
.html). AIN93G control diet (CD), protein-restricted diet
(PR), and protein-restricted diet supplemented with folic
acid (FA) were used as experimental diets in recipient
mothers beginning 1 month before ET until delivery. The
nutrient sources of these experimental diets are described
in Table 1. Neonates were adopted by ICR foster mothers
immediately after cesarean section. After weaning, we pro-
vided the CD to the progenies. The body weight of the
mothers and progenies, clinical biochemistry of the recipi-
ent mothers, gene expression in the brain of the progen-
ies, and behavioral phenotypes of the progenies were
examined.
Experimental diets
The CD was very similar to the standard formation of
AIN93G [15]. Test diets were modified from AIN93G for-
mulation as follows: PR, ratio of vitamin-free casein was
decreased from 20 to 5%; FA, 0.8 g/kg of folic acid was
added to the PR (Table 1). The CD and PR contained
0.02% folic acid (weight composition) and the FA con-
tained 0.1% folic acid (weight composition). Experimentaldiets were purchased from a commercial supplier (Oriental
yeast Co. Ltd, Tokyo, Japan). These diets were isocaloric
(4 kcal/g in each feed) and fed to the recipient mothers ad
libitum. In addition, only the CD diet was fed to the foster
mothers ad libitum.
Mice
All mice used as recipient and foster mothers, as well as
for egg and sperm collection, were purchased from a
commercial supplier (CLEA Japan, Inc.).
In vitro fertilization and embryo transfer
We conducted IVF and ET as previously described [16]
to produce mice for behavioral tests, expression array,
and DNA-methylation analysis of brains. In brief, sperm
was collected from the caudae epididymides of 25-week-
old B6 males and allowed to diffuse in fertilization
medium. After preincubation for approximately 1 h to
allow for capacitation, the sperm was used for insemin-
ation. Meanwhile, 3-week-old female mice (N = 7) were
superovulated using intraperitoneal injections of PMSG
and HCG (serotropin and gonatropin; ASKA Pharma-
ceutical Co., Tokyo, Japan) with an interval of 48 h be-
tween injections. Approximately 15–17 h after the HCG
injection, the oocytes-cumulus complexes were collected
from the oviducts of superovulated female B6 mice. Then,
the complexes from several female mice were placed in
fertilization medium. Insemination was performed by add-
ing the preincubated sperm suspension to the fertilization
medium containing complexes and cultured at 37 °C with
5% CO2. 24 h after insemination, 24 2-cell embryos were
transferred into the oviducts of pseudopregnant ICR fe-
males (CLEA Japan, Inc.) mated to vasectomized ICR
males. ICR females that consumed experimental diets were
used as pseudopregnant recipients for the ET. Female ICR
mice were purchased at 4 to 5 weeks of age, and intro-
duced to the facility for experiments. These mice were split
randomly into three groups; CD, PR, and FA. The foster
mothers consumed the experimental diets beginning
4 weeks before ET and continuing until delivery. Body
weight of recipient mice was measured once per week until
delivery via cesarean section [17]. We used only male pro-
geny for behavioral, genomic methylation, and gene ex-
pression analyses. Maternal separation in early life alters
behavioral phenotypes, gene expression, and brain func-
tions of mice [18, 19]. Hence, newborn male mice had to
be adopted by foster mothers immediately after cesarean
section (6–7 neonates/foster mother), and body weights
were not measured. However, we measured body
weights of female neonates to determine the effects of
maternal hyponutrition on birth weight of offspring im-
mediately after cesarean section. In order to reduce the
number of foster mothers, only males were adopted by
foster mothers.
Fig. 1 Experimental strategy. The experimental design of this study is briefly described. Normal diet (CE-2) was fed to females used for oocyte
collection and males used for sperm collection. Recipient mothers consumed the control diet (CD) or experimental diet (PR and FA) for 1 month
before embryo transfer. Embryos were generated by fertilizing the eggs with sperm of C57BL/6J (B6) mice. After cesarean-section delivery, neonates
were fostered by ICR females that had consumed CD, PR, or FA diets. After weaning, offspring consumed the control diet (CD). Serum was separated
from blood taken from the ICR females. Brain tissue was collected from offspring after behavioral tests
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We carried out a clinical-biochemical test using serum
collected from ICR females at 13 weeks of age. The mice
consumed experimental diets for 7 weeks. Blood collec-
tion, separation of serum, and analysis was performed as
previously described [20]. In brief, we collected 200 μl of
blood from the retro-orbital sinus using a Pasteur pip-
ette (Thermo Fisher Scientific Inc., Waltham, MA). The
collected blood was transferred to a microtube contain-
ing Coagulant Wako solution (Wako Pure Chemical
Industries Co, Osaka, Japan) and serum was separated
by centrifuging twice (600–2500×g for 5–15 min). We
measured total protein (TP), urea nitrogen (UN), albu-
min (ALB), total cholesterol (T-CHO), HDL-cholesterol
(HDL-C), triglyceride (TG), and LDL-cholesterol (LD-C)
in the serum with an automatic clinical-biochemistryanalyzer (JCA-BM2250, JEOL, Ltd., Tokyo, Japan). Num-
ber of subjects: CD, 7; PR, 7; FA, 6.DNA/RNA extraction
We harvested whole brains from adult male progenies
(19 weeks of age) that were used in behavioral analyses,
methylation analyses, and expression arrays. Adult males
were euthanized via cervical dislocation. Brain samples
were rinsed with PBS and frozen immediately using li-
quid nitrogen. The frozen tissues were stored at −80 °C.
RNA and DNA were extracted simultaneously using an
AllPrep DNA/RNA Mini Kit (Qiagen, Valencia, CA,
USA) from the whole brains, including cerebrum and
cerebellum. We then performed gene methylation and
expression arrays as described below.
Table 1 Components of experimental diets
Composition (% weight)
Component CD PR FA
Vitamin-free casein 20 5.0 5.0
L-cystine 0.3 0.077 0.077
Corn starch 39.7486 51.1716 51.1716
Alpha-corn starch 13.2 17.0 17.0
Sucrose 10.0 10.0 10.0
Soy bean oil 7.0 7.0 7.0
Cellulose powder 5.0 5.0 5.0
AIN-93G mineral mixture 3.5 3.5 3.5
AIN-93 vitamin mixture 1.0 1.0 1.0
Folic acid 0.02 0.02 0.1
Choline bitartrate 0.25 0.25 0.25
Tertiary butylhydroquinone 0.0014 0.0014 0.0014
Total 100.0 100.0 100.0
CD control diet, PR protein-restricted diet, FA PR diet with
supplemental-folic acid
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Genome-wide DNA methylation analysis was performed
as previously reported with slight modification [21]. Gen-
omic DNA was fragmented with methylation-insensitive
restriction enzymes (MseI, BfaI, and CSP6I) to yield frag-
ments ranging in size from 200 to 1000 base pairs. The
enrichment of methylated DNA was performed using the
MethylMiner Methylated DNA Enrichment kit (Thermo
Fisher Scientific Inc.). Briefly, CpG-dense methylated
DNA was isolated from fragmented genomic DNA via
binding to the methyl-CpG domain of the MBD2 protein,
which is coupled to paramagnetic Dynabeads M-280
streptavidin via a biotin linker. A portion of the fragmen-
ted DNA (input) was left untreated and used as a control.
DNA was amplified and cleaned using the GenomePlex
Complete Whole Genome Amplification (WGA) Kit and
GenElute PCR Clean-Up Kit (Sigma-Aldrich St. Louis,
MO, USA). For analysis of genomic methylation, we used
the Mouse Promoter 1.0R Array (Affymetrix) against
methylated (IP) and input DNA (IN). Number of subjects:
CD, 3; PR, 4; FA, 4.
Expression array
Expression analysis by DNA microarray was performed
with the Agilent system (G4846A; Whole Mouse Genome
Microarray Kit (4x44K) Agilent Technologies, Santa Clara,
CA, USA). The probes for the microarray were prepared
and labeled by Cy3 according to the manufacturer’s
protocol (Agilent Technologies). Arrays were scanned
with a G2505C Microarray Scanner System (Agilent
Technologies). Data were normalized using the R
stats package with the qspline function of the “affy”
package in the Bioconductor [22].Validity of the methylation and expression array data
Results of methylation array analyses have been vali-
dated in previous studies [21, 23]. In these studies, the
array-based methylation quantification data showed
strong concordance with results obtained from bisulfite
sequencing (r = 0.81 to 0.88) [21, 24]. In addition, ex-
pression array data was also validated in previous stud-
ies. Expression data obtained by the one color
microarray platform showed strong concordance with a
TaqMan assay (r = 0.876) in a large scale microarray
quality control project [25].
Data availability
Expression and methylation array data were deposited in
the NCBI gene expression omnibus (http://www.ncbi.nlm.-
nih.gov/geo/) and accession numbers of the datasets are as
follows: GSE79847.
Behavioral tests
We performed the following behavioral tests: open-field
test (6-weeks-old), object-exploration test (7-weeks-old),
social-interaction test (8-weeks-old), home-cage activity
test (9 to 10-weeks-old), light/dark-transition test (11-
weeks-old), fear-conditioning test (12-weeks-old), and
tail-suspension test (13-weeks-old). Results of the behav-
ioral tests are sensitive to prior experiences [26]. To sup-
press effects of prior experiences, the behavioral tests
were performed in order of less stimulation as described
above. We used male mice for the behavioral tests in
order to eliminate the effects of the estrous cycle in fe-
males. Number of subjects: CD, 10; PR, 10; FA, 7.
Open-field test
Open-field test was performed as previously described
[27]. Each mouse was placed in the corner of an open-
field apparatus (400 mm wide × 400 mm long × 300 mm
high; O’Hara & Co., Ltd., Tokyo, Japan) made of white
polyvinyl chloride. The distance traveled by each animal
in the open-field was recorded for 20 min with a video-
imaging system (Image OF9; O’Hara & Co., Ltd.).
Object-exploration test
We performed an object-exploration test as previously
described [27]. Briefly, each mouse was placed in the
open-field apparatus without the novel object for 20 min
of acclimation before testing. A transparent acrylic tube
(bottom diameter, 66 mm; top diameter, 44 mm; height,
154 mm) containing marbles was placed in the center of
the open-field. The total time spent exploring the object
and frequency of exploration during a 10 min period
was determined with a commercial video-imaging sys-
tem (O’Hara & Co., Ltd.). Exploration was defined as a
distance of < 1 cm between the object and the mouse.
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A social-interaction test was performed as previously de-
scribed [27]. We used a procedure similar to the object-
exploration test to examine social-interaction behavior
in mice. A mouse was positioned in the center of the
open-field apparatus with an empty transparent acrylic
tube and habituated for 20 min. Then, the empty tube
was exchanged for another tube containing a novel male
mouse, which was placed in the center of the open field.
The total time spent exploring the novel mouse and the
frequency of exploration during a 10-min period was de-
termined by video-imaging.
Home-cage activity
A home-cage activity test was performed as previously
described [27]. Each mouse was placed alone in a testing
cage (227 × 329 × 133 mm) under a 12 h light–dark cycle
(light on at 08:00 am) and had free access to both food
and water. After 1 day of acclimation, spontaneous activ-
ity in the cage was measured for 5 days (starting at
08:00 am) using an infrared sensor (activity sensor,
O’Hara & Co., Ltd.).
Light/dark transition test
A light/dark transition test was performed as described
previously [27]. A commercially available light/dark cham-
ber (O’Hara & Co., Ltd.) consisting of a light chamber
(200 mm long × 200 mm wide × 250 mm high) made of
white vinyl chloride plates and a dark chamber with the
same dimensions made of black vinyl chloride plates was
used. The apparatus had an opening (50 mm wide ×
30 mm high) in the middle of the wall joining the two
chambers. The opening was controlled by a guillotine
door. The number of transitions between chambers, time
spent in the light chamber, and the total distance traveled
by the mouse were measured.
Fear-conditioning test
We performed a fear-conditioning test as previously de-
scribed [28] with slight modification. On the training
day (day 1), each mouse was placed in a shock chamber
with white walls (O’Hara & Co. Ltd.) (box A) and 120 s
later, 4 tone-shock pairs were given at 90 s intervals.
Each tone-shock pair consisted of a tone (70 dB,
10 kHz) for 30 s and a foot shock for 2 s at 0.5 mA. The
foot shock was presented to the mice during the last 2 s
of the tone. On day 2, each mouse was placed back in
box A for 6 min to measure contextual freezing. On day
3, each mouse was placed in a white transparent cham-
ber (box B), and 180 s later, 180 s tones were delivered.
Freezing was measured during the first 180 s in box B,
representing the response to an unconditioned context,
and then during the next 180 s in the presence of the
conditioned tone.Tail-suspension test
In order to examine depression-like behavior in the pro-
genies, a tail-suspension test was performed as described
previously [29] with slight modifications. The tail of the
mouse was fixed to a metal plate using adhesive tape.
Then, the mouse was suspended from the metal plate in
an experimental box (400 mm × 400 mm × 300 mm;
O’Hara and Co., Ltd.). The duration of immobility of the
mouse was measured using a video-analysis system
(O’Hara & Co., Ltd.) for 6 min.
Statistical analyses
Body weights, blood biochemistry, and behavioral tests
For the behavioral tests, we analyzed the data obtained
from each group using one-way or two-way ANOVA. In
case of a significant difference detected by ANOVAs,
post-hoc analysis (Fisher’s PLSD) was performed.
Methylation analysis
For the methylation analysis, microarray data were ana-
lyzed using Partek Genomics Suite software (PGS) 6.6
(Partek, Inc.). Data normalization was performed by the
default method, including adjusting the probe sequence,
RMA Background Correction, Quantile Normalization,
and Log (base 2) transformation [23]. Data quality was
assessed using PCA and the application of Partek’s qual-
ity control workflow. The baseline normalization was
performed using the matched-pair normalization tool in
PGS, by subtracting the average of IN signals from each
IP signal. To detect the MBD binding (methylated)
regions in PR or FA relative to CD, we performed a one-
way ANOVA and calculated the fold change using
geometric mean. Significant region detection (hyper-
methylation and hypomethylation) was performed
using hidden Markov model (HMM) tool in PGS as
previously reported [23]. Briefly, in order to capture
significant differences in enrichment in PR or FA vs
CD across shorter genomic regions (min. ~350 nucle-
otides) with robust enrichment differences as well as
intermediate (min. ~500 nucleotides) and large re-
gions (min. ~1400 nucleotides), three HMM algo-
rithms were applied (s-HMM, m-HMM, and l-HMM).
The following cutoffs were used: s-HMM (min. probes: 5,
detection states: −5,5, ignore state: 0, max. probability:
0.99, genomic decay: 10000, sigma: 2), m-HMM (min.
probes: 10, detection states: −3,3, ignore state: 0, max.
probability: 0.99, genomic decay: 10000, sigma: 1), and l-
HMM (min. probes: 40, detection states: −1.5,1.5, ignore
state: 0, max. probability: 0.99, genomic decay: 10000,
sigma: 1).
Gene expression
To determine the genes that showed differential expression
among the three experimental groups, Tukey’s multiple
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adjusted by Benjamini and Hochberg false discovery rate
(BHFDR) to correct multiple tests using the R package.
Statistical significance was assumed at P < 0.0001. The
genes that were expressed differently among the groups at
the twofold or 0.5-fold change and P < 0.0001 level after the
BHFDR were regarded as differentially expressed genes.
Venn diagrams list of differentially methylated and
expressed genes were drawn using the R package with the
“VennDiagram” function.
Results
Body weight and protein-related parameters of recipient
mothers
The experimental design is briefly described in Fig. 1.
The three different diets used in this study were protein-
restricted (PR), folic acid-supplemented PR (FA), and the
control diet (CD) (Table 1). Folic acid is a critical co-
enzyme for DNA methylation and may affect epigenetic
modification [30]. Oocytes and sperm were obtained
from females and males, respectively, which were fed a
normal diet (CE-2). In vitro fertilized eggs were trans-
ferred to three different kinds of ICR recipient mothers
that consumed the PR, FA, or control diet (CD) 1 month
before the embryo transfer. Fetuses/neonates were ob-
tained by caesarian section from mothers at 20 days of
gestation, and immediately transferred into the care of
an ICR foster mother that had consumed the PR, FA, or
CD diet. After weaning, offspring consumed the CD.
Figure 2a shows average body weights of the recipient
mothers of the three different dietary conditions. Similar
increases in body weight were observed between the CD
and the PR groups at 6–11 weeks of age before ET from
B6 mice (two-way ANOVA (Additional file 1)). However,
1 and 2 weeks after the ET (12–13 weeks age), recipient
mothers of the PR and FA groups exhibited significantly
lower body weights than that of the CD group (two-way
ANOVA (Additional file 1)) (Fig. 2a). We performed
clinical-biochemical tests in ICR females at 13 weeks of
age that consumed experimental diets for 7 weeks.
Serum levels of protein-related components such as TP,
UN, and ALB (Fig. 2b–d) were significantly lower in the
PR and FA groups than in the CD group (one-way
ANOVA (Additional file 1)). This may be consistent with
differences in body weight. However, as for parameters
related to lipid metabolism, levels of total T-CHO and
HDL-C were higher in the PR and FA groups than in
the CD group (one-way ANOVA (Additional file 1))
(Fig. 2e, f ), whereas the TG level was lower (one-way
ANOVA (Additional file 1)) (Fig. 2g). We also measured
body weights of their progenies from postnatal day 0
and 4 to 12 weeks of age (Additional file 2: Figure S1 A
and B). No difference was observed among the three
groups with ANOVA, indicating little effect of foodcomponents on body weight gain of the progeny (one-
way ANOVA (Additional file 1)). In addition, no differ-
ence was detected in the performance of embryo transfer
among the three groups (Additional file 3: Table S1).
Effects of maternal-protein restriction on behavioral
phenotypes of progeny
Several tests were performed to examine the behaviors
of progenies, and some showed significant changes due
to the maternal metabolic changes described above.
The open-field test examining locomotor activity in
novel place, an indicator for fear/anxiety-like behavior,
showed differences between the study groups. We failed
to detect changes in the distance that mice traveled in
the open-field arena among the three different progen-
ies (two-way ANOVA (Additional file 1)) (Fig. 3a) but
found shorter times or durations spent in the center
area (30% of the whole arena) in the PR and FA groups
than that in the CD group of mice at 7 weeks of age
(two-way ANOVA (Additional file 1)) (Fig. 3b). This in-
dicates increased fear/anxiety like behavior in the PR
and FA groups [31]. The object-exploration test exam-
ining novelty seeking behavior also showed differences
between the study groups. In this test, the duration of
active contacts to a novel object was decreased in the
PR group relative to that of the CD group (two-way
ANOVA (Additional file 1)) (Fig. 3c). In addition, the
number of contacts with the object was significantly de-
creased in the PR and FA groups (two-way ANOVA
(Additional file 1)) (Fig. 3d). The social interaction test
examining prosocial behavior of mice found that the PR
and FA groups exhibited shorter durations of active
contacts with a novel mouse than that of the CD group
(two-way ANOVA (Additional file 1)) (Fig. 3e), as well
as decreased number of contacts (two-way ANOVA
(Additional file 1)) (Fig. 3f ).
We failed to detect differences in the other tests, such
as fear-related behavior in a light/dark-transition test
(one-way ANOVA (Additional file 1)) (Additional file 4:
Figure S2A–C), contextual and cued learning and mem-
ory (one-way ANOVA (Additional file 1)) (Additional
file 5: Figure S3A, B), and depressive behavior in a tail-
suspension test (one-way ANOVA (Additional file 1))
(Additional file 6: Figure S4) between the three groups.
Figure 3g–i shows the effect of supplemented folic acid
on locomotor activity, which was measured by the
home-cage activity test in a familiar setting and daily ac-
tivity patterns under a light and dark cycle. The mean
activity over 5 days in the home cage is expressed as the
activity during the light phase (Fig. 3g), activity during
the dark phase (Fig. 3h), and activity patterns during the
light/dark cycle (Fig. 3i). During the light phase, no dif-
ference was observed in the locomotor activity among
all groups (one-way ANOVA (Additional file 1)) (Fig. 3i).
Fig. 2 Body weight changes in recipient mothers and serum levels of clinical-biochemical parameters in ICR females. a Body weights of recipient
mothers is shown. Arrowhead indicates the day of embryo transfer. Number of subjects: CD, 11; PR, 14; FA, 14. b–h Serum levels of clinical biochemical
parameters in ICR females. (b), total protein (TP); (c), urea nitrogen (UN); (d), albumin (ALB); (e), total cholesterol (T-CHO); (f), HDL cholesterol (HDL-C);
(g), triglyceride (TG) in ICR females that consumed CD, PR, and FA for 1 month are shown. Number of subjects, CD, 7; PR, 7; FA, 6. a–g Data represent
the mean ± SEM. Asterisks indicate significant differences between groups in post hoc analyses (Fisher’s PLSD test, ***: P < 0.0001, **: P < 0.01,
*: P < 0.05)
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motor activity than that of the CD groups (one-way
ANOVA (Additional file 1)) (Fig. 3h), and interest-
ingly, this increase was abrogated by folic acid sup-
plementation (one-way ANOVA (Additional file 1))
(Fig. 3h). No difference, however, was observed in
the locomotor activity patterns between PR and FA
groups (Fig. 3i).
Collectively, these results suggest that PR diet in re-
cipient mothers, irrespective of FA supplementation,
enhances susceptibility to fear/anxiety-like, novelty
seeking, and prosocial behaviors of progenies.Effect of protein restriction on epigenetic alterations
One may expect to find differences in genomic methyla-
tion and gene expression among the three different
groups. Thus, we performed genome-wide DNA methy-
lation analysis of the three study groups by MBD-chip.
The raw data was analyzed using Partek Genome Suite
(PGS) software to detect the significantly differentially
enrichment regions, as previously reported (see
methods). A total of 292 HMM regions exhibited lower
promoter methylation levels in the PR group than in the
CD group (Additional file 7), whereas 264 HMM regions
were higher in the PR group (Additional file 8). A total
Fig. 3 Results of behavioral tests of progenies. a, b Results of open-field test at 7 weeks of age. a Locomotor activity patterns during the open-field test
at 7 weeks of age. b Time spent in the center (30% of the open-field arena) at 7 weeks of age. c, d Results of object-exploration test. c Time spent
exploring a novel object. d Number of times mice that made contact with a novel object. e, f Results of social-interaction test. e Time spent exploring
a novel mouse. Number of subjects: CD, 9; PR, 10; FA, 7. f Number of times mice made contact with a novel mouse. g–i Locomotor activity of mice in
their home cages. g Mean locomotor activity during the light period. h Mean locomotor activity in the home cage during the dark period. i Locomotor
activity in the home cage during the light/dark cycle. a–i Number of subjects: CD, 10; PR, 10; FA, 7. Data represent the mean ± SEM. Asterisks indicate
significant differences between groups in post hoc analyses (Fisher’s PLSD test, *: P < 0.05)
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the CD group in methylation level. A total of 272 HMM
regions exhibited lower promoter methylation levels in
the FA group than in the CD group (Additional file 9),
whereas 222 HMM regions were higher in the PR group
(Additional file 10). A total of 383 genes significantly dif-
fered between the FA and the CD group in methylationlevel. A total of 169 HMM regions exhibited lower pro-
moter methylation levels in the FA group than in the PR
group (Additional file 11), whereas 127 HMM regions
were higher in the PR group (Additional file 12). A total
of 211 genes significantly differed between the FA and
the CD group in methylation level. In the expression
array, there were 25 genes with lower expression levels
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BHFDR) and 55 with higher expression levels (greater
than 2.0 fold change and P < 0.0001 level after the
BHFDR) (Additional files 13 and 14) in the PR group
relative to the CD group. There were 48 genes with
lower expression levels (less than 0.5-fold change and P
< 0.0001 level after the BHFDR) and 81 with higher ex-
pression levels (greater than 2.0-fold change and P <
0.0001 level after the BHFDR) (Additional files 15 and
16) in the PR group relative to the CD group. There
were 2 genes with lower expression levels (less than 0.5-
fold change and P < 0.0001 level after the BHFDR)
and 3 with higher expression levels (greater than 2.0-
fold change and P < 0.0001 level after the BHFDR)
(Additional files 17 and 18) in the FA group relative
to the PR group. In addition, differentially expressed genes
in the PR and FA groups relative to the CD group did not
intersect with differentially methylated genes in the PR
and FA groups relative to the CD group.
Discussion
In the present study, we examined the effect of maternal
hyponutrition because of a PR diet on developmental
and mental disorders of the progenies by comprehensive
phenotyping of behaviors. The examination included
seven different assays for fear/anxiety-like, novelty seek-
ing, and prosocial behaviors, as well as others that may
be related to AD/HD- and ASD-like behaviors. We
found significant differences in the assays for fear/anx-
iety-like, novelty seeking, and prosocial behaviors, which
suggests that environmental factors in the embryo/fetus
play an important role in the susceptibility of the pro-
genies to these behaviors. This may be parallel to epi-
demiological studies showing that environmental or
nutritional factors affect behavioral symptoms of AD/
HD [32] and ASD [33].
A previous study on diet-induced effects reported an
increase in the locomotor activity and a lower birth
weight of progeny without weight loss in mothers [9].
However, it was conducted under conditions of natural
fecundation that did not exclude confounding variables
such as the formation of the egg before insemination,
milk composition during lactation, and maternal nursing
behavior. To exclude those confounding or additional
factors pre and postgestation, we used IVF, which
allowed us to examine only the effect of diet-induced en-
vironmental changes in utero during implantation and
gestation. A similar attempt was performed in a recent
study examining a transgenerational effect of diet on
metabolic diseases [34]. In addition, we used a PR diet
supplemented with folic acid to exclude the effect of
folic acid on DNA methylation-mediated epigenetic
modification. In fact, Lillycrop et al. reported that FA
supplementation prevents epigenetic modification ofhepatic gene expression in offspring [8]. As expected,
the PR and FA diets caused differences in gene expres-
sion and genomic methylation in the brains of adult pro-
genies. However, only a moderate proportion of the
differences between PR and CD diets were abrogated by
FA supplementation. In addition, the FA group showed
a different methylation pattern relative to that of the PR
group, whereas adult progenies of FA group exhibited
behavioral alterations similar to those in the PR group.
These results suggest a moderate contribution of FA to
the effects of PR on behaviors. Analysis of recipient
mothers showed decreases in protein-related compo-
nents in serum such as TP, UN, and ALB, as well as the
triglyceride levels, which were consistent with a decrease
in body weight of the mothers, and increases in levels of
total cholesterol, HDL-C, and LDL-C. These changes
may underlie environmental changes in utero during
implantation and gestation, which could cause suscepti-
bility of the offspring.
Several reports have examined AD/HD and ASD
mouse models lacking certain gene functions [35–38].
AD/HD models lacking genes related to the dopamin-
ergic system clearly exhibited a deficiency in sustained
attention and elevated locomotor activity [35, 38],
whereas ASD models lacking genes related with func-
tions of GABAergic and oxytocin related neurons
showed decreased social approach [39] and increased
fear/anxiety-like behaviors [40]. These behavioral alter-
ations were observed in this study, but the level of differ-
ences was moderate. In a previous report, the progenies
of B6 mothers that consumed a protein-restricted diet
were found to have a lower birth weight relative to the
control group; however, the body weight of the mothers
were not altered [9]. In the study, the B6 strain was used
for mothers and DBA/2 strain was used for fathers of
progenies [9], whereas in the present study we used ICR
females as recipient mothers and B6 as the source of the
embryo. We provided experimental diets to pre-
pregnant and pregnant ICR females, and the females
that consumed the PR and FA diets exhibited abnormal
metabolism of protein relative to the CD group in a
clinical-biochemical test. This did not result in lower
body weight of these pre-pregnant females; however,
pregnant females of the PR group exhibited significantly
lower body weight relative to the CD group. Addition-
ally, the progenies of the PR group did not exhibit lower
birth weights. Although the amount of protein in the PR
group was sufficient for development in newborn mice,
it might have been insufficient for body weight gain in
the pregnant females. According to the observed pheno-
type of mice in our previous study [41], the body mass
of the ICR strain is much larger than that of the B6
strain. Thus, accumulated protein source in the ICR fe-
males may have compensated for the insufficient protein
Furuse et al. Genes & Nutrition  (2017) 12:1 Page 10 of 12diet in the fetuses of the PR group. In addition, neonates
from the ICR females that were fed experimental diets
were nursed by the foster mothers that were fed the CD.
IVF and ET, which are assisted reproductive technolo-
gies, are thought to induce epigenetic changes in the
embryo and to alter the adult phenotype in humans [42].
Hence, these differences in experimental conditions re-
sulted in different behavioral phenotypes exhibited by
the progenies in the present and previous studies. There-
fore, pre-insemination and postnatal/lactation effects of
maternal hyponutrition may play a similarly important
part in determining offspring behavioral phenotypes.
As in a previous study [9], the present study used only
male mice for the behavioral tests in order to eliminate
phenotypic variation in female mice caused by the
desynchronization of the estrous cycle. The B6 mouse
exhibits sex dimorphisms in several behavioral pheno-
types, including motor function in the rotarod test,
learning and memory in the Morris water-maze test and
the fear conditioning test, and locomotor activity in the
open-field test [43]. The moderate effects of maternal
protein restriction on behavioral phenotypes of the pro-
genies observed in the present study may be gender-
specific phenomena.
The methylation levels of promoters in these genes were
not correlated with expression levels of the genes. The epi-
genetic alterations in the brain of the progenies induced by
the maternal-protein restriction were clearly observed in
the present study. A causal link between epigenetic and be-
havioral alterations remains to be investigated.
The results of the present study suggest that although
maternal protein restriction during pregnancy is a mod-
erate risk factor for developmental or mental disorders
of the progeny, it may be substantiated by interaction
with genetic factors, including specific mutations or gen-
etic variations. In addition, pre-insemination and postna-
tal/lactation effects of maternal hyponutrition may
significantly contribute to the phenotype.
To verify this hypothesis, it may be necessary to exam-
ine the effect of hyponutritional exposure in utero on
known developmental disorder models, such as AD/HD
and ASD models, or other mouse strains, and to clarify
the additive consequences or interaction for behavioral
phenotypes.
Conclusions
The PR group exhibited fear/anxiety related behaviors
and inattention to a novel object or a novel mouse more
than those of the control diet group. As might be ex-
pected, adult brains of the PR group exhibited differ-
ences in patterns of the expression array analysis and of
genomic-methylation.
Environmental factors in the embryo/fetus play an im-
portant role in susceptibility to alteration of progenies’behaviors. The present study is, to our knowledge, the
first to evaluate the effect of maternal hyponutrition on
behavioral phenotypes using reproductive technology.Additional files
Additional file 1: Values of the statistical analysis. (PDF 155 kb)
Additional file 2: Figure S1. Body-weight changes in progeny. (A) Body
weight of progeny immediately after delivery with caesarean section is
shown. Number of subjects: CD, 9; PR, 6; FA, 5. Female neonates were
used. (B) Body weight of progeny at 4 to 12 weeks of age is shown.
Number of subjects: CD, 10; PR, 10; FA, 7. Male mice were used. Data
represent the mean ± SEM. (TIF 147 kb)
Additional file 3: Table S1. Performance of embryo transfer in recipient
mothers. Mean litter sizes of offspring from each recipient mother are
shown. Twenty-four embryos (2-cell) were transferred to each recipient
mother. Results of ANOVA analysis, main effect of diet, F(2, 36) = 0.874,
P > 0.42. (DOCX 21 kb)
Additional file 4: Figure S2. Light/dark transition test. (A) The number
of transition between the light and dark chambers. (B) Time spent in
light chamber. (C) Total distance traveled. (A-C) Number of subjects: CD,
10; PR, 10; FA, 7. Data represent the mean ± SEM. (TIF 179 kb)
Additional file 5: Figure S3. Results of fear conditioning test. (A)
Freezing responses pre- and post-training with three tone-shock pairs in
box A. Pre-train indicates the freezing levels in box A (the shocking
chamber) before the onset of training. Context indicates the freezing
level after training. (B) Freezing responses with no tone and during tone
in box B. (A, B) Number of subjects: CD, 6; PR, 10; FA, 7; Data represent
the mean ± SEM. (TIF 125 kb)
Additional file 6: Figure S4. Tail-suspension test. Percent of immobility
time in five minutes is shown. Data represent the mean ± SEM. Number
of subjects: CD, 6; PR, 10; FA, 7. (TIF 79 kb)
Additional file 7: Supplemental information 1. HMM regions in which
methylation levels were lower in PR group relative to CD group. Table
also includes identifiers such as gene symbol, Transcript ID, Distance to
TSS, percent overlap with region, precise chromosome location of the
region, region length, PGS region ID, markers (number of probes), mean
enrichment level across the region (fold enrichment), and HMM state
(s-HMM: -5, m-HMM: -3, l-HMM: -1.5). (CSV 25 kb)
Additional file 8: HMM regions in which methylation levels were higher
in PR group relative to CD group. Table also includes identifiers such as
gene symbol, Transcript ID, Distance to TSS, percent overlap with region,
precise chromosome location of the region, region length, PGS region ID,
markers (number of probes), mean enrichment level across the region
(fold enrichment), and HMM state (s-HMM: +5, m-HMM: +3, l-HMM: +1.5).
(CSV 23 kb)
Additional file 9: HMM regions in which methylation levels were lower
in FA group relative to CD group. Table also includes identifiers such as
gene symbol, Transcript ID, Distance to TSS, percent overlap with region,
precise chromosome location of the region, region length, PGS region ID,
markers (number of probes), mean enrichment level across the region
(fold enrichment), and HMM state (s-HMM: -5, m-HMM: -3, l-HMM: -1.5).
(CSV 24 kb)
Additional file 10: HMM regions in which methylation levels were
higher in FA group relative to CD group. Table also includes identifiers
such as gene symbol, Transcript ID, Distance to TSS, percent overlap with
region, precise chromosome location of the region, region length, PGS
region ID, markers (number of probes), mean enrichment level across the
region (fold enrichment), and HMM state (s-HMM: +5, m-HMM: +3,
l-HMM: +1.5). (CSV 19 kb)
Additional file 11: HMM regions in which methylation levels were
lower in FA group relative to PR group. Table also includes identifiers
such as gene symbol, Transcript ID, Distance to TSS, percent overlap
with region, precise chromosome location of the region, region
length, PGS region ID, markers (number of probes), mean enrichment
Furuse et al. Genes & Nutrition  (2017) 12:1 Page 11 of 12level across the region (fold enrichment), and HMM state (s-HMM: -5,
m-HMM: -3, l-HMM: -1.5). (CSV 15 kb)
Additional file 12: HMM regions in which methylation levels were
higher in FA group relative to PR group. Table also includes identifiers
such as gene symbol, Transcript ID, Distance to TSS, percent overlap with
region, precise chromosome location of the region, region length, PGS
region ID, markers (number of probes), mean enrichment level across the
region (fold enrichment), and HMM state (s-HMM: +5, m-HMM: +3,
l-HMM: +1.5). (CSV 11 kb)
Additional file 13: List of genes that exhibited lower expression level in
PR group relative to CD group in adult brain. Table also includes
identifiers such as probe name, PrimaryAccession ID, GeneSymbol, Gene
ontology (GO), Gene description, chromosome number, P value in
Tukey’s multiple comparison test adjusted by FDR, and mean fold change
of expression level. (CSV 11 kb)
Additional file 14: List of genes that exhibited higher expression level
in PR group relative to CD group in adult brain. Table also includes
identifiers such as probe name, PrimaryAccession ID, GeneSymbol, Gene
ontology (GO), Gene description, chromosome number, P value in
Tukey’s multiple comparison test adjusted by FDR, and mean fold change
of expression level. (CSV 18 kb)
Additional file 15: List of the genes which exhibited lower expression
levels in FA group relative to CD group. Table also includes identifiers
such as probe name, PrimaryAccession ID, GeneSymbol, Gene ontology
(GO), Gene description, chromosome number, P value in Tukey’s multiple
comparison test adjusted by FDR, and mean fold change of expression
level. (CSV 21 kb)
Additional file 16: List of the genes which exhibited higher expression
levels in FA group relative to CD group. Table also includes identifiers
such as probe name, PrimaryAccession ID, GeneSymbol, Gene ontology
(GO), Gene description, chromosome number, P value in Tukey’s multiple
comparison test adjusted by FDR, and mean fold change of expression
level. (CSV 27 kb)
Additional file 17: List of genes that exhibited lower expression level in
FA group relative to PR group in adult brain. Table also includes
identifiers such as Probe name, PrimaryAccession ID, GeneSymbol, Gene
ontology (GO), Gene description, chromosome number, P value in
Tukey’s multiple comparison test adjusted by FDR, and mean fold change
of expression level. (CSV 1 kb)
Additional file 18: List of genes that exhibited higher expression level
in FA group relative to PR group in adult brain. Table also includes
identifiers such as Probe name, PrimaryAccession ID, GeneSymbol, Gene
ontology (GO), Gene description, chromosome number, P value in
Tukey’s multiple comparison test adjusted by FDR, and mean fold change
of expression level. (CSV 1 kb)
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